Lawmakers and health experts convened on Capitol Hill this week to discuss the use of AI in healthcare. They highlighted the technology’s potential to reduce administrative burdens and boost care access in rural areas — while also warning about oversight gaps and the risks of AI-driven prior authorization. The post What Did Lawmakers Discuss at the House Hearing on Health AI? appeared first on MedCity News.| MedCity News
The pathway for health plans to achieve better Star ratings performance in their MA business depends on creating an ecosystem where providers are supported with the right tools and resources, incentives are properly aligned, and the member experience remains central to all initiatives. The post What’s Missing from Your Tool Chest? How Health Plans Can Improve Star Ratings in Medicare Advantage appeared first on MedCity News.| MedCity News
Out of the 476 ACOs that participated in the Medicare Shared Savings Program in 2024, 75% earned $4.1 billion in performance payments, CMS reported. The post CMS: ACOs in Shared Savings Program Saved Medicare $2.4B in 2024 appeared first on MedCity News.| MedCity News
August has seen a slew of executive hires, exits and layoffs across the healthcare sector. For example, OpenAI, Veradigm and Qure.ai welcomed new executives. There were also layoffs at organizations including BioNTech, CentraCare and Emory Healthcare. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.| MedCity News
As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry.| MedCity News
In February 2025, the FDA gave IND approval to United Therapeutics for the first xenotransplantation clinical trial, which followed a series of high-profile transplants via the compassionate use pathway from both United and rival eGenesis. Collectively, these milestones have created buzz around the potential for xenotransplantation to address the growing burden of End Stage Kidney […]| Recon Strategy
